Not available
Quote | Merck & Company Inc. (NYSE:MRK)
Last: | $125.885 |
---|---|
Change Percent: | 0.09% |
Open: | $125.95 |
Close: | $125.77 |
High: | $126.49 |
Low: | $125.03 |
Volume: | 2,030,120 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Merck & Company Inc. (NYSE:MRK)
2024-07-21 21:02:13 ET More on health care stocks Elevance Health: Buy A Dividend Growth Machine Elevance extends losses as BofA cuts on Medicaid headwinds What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Merck: Among The Best Health Ca...
2024-07-21 07:00:00 ET More on AstraZeneca, Bristol-Myers, etc. Bristol-Myers Squibb - Investors Are Too Long-Term Focused Bristol-Myers Squibb Is A Bargain Now AstraZeneca Stock: Upgrading From 'Hold' To 'Buy' Ahead Of Q2 2024 Earnings Dividend Roundup: Gold...
Message Board Posts | Merck & Company Inc. (NYSE:MRK)
Subject | By | Source | When |
---|---|---|---|
$MRK reports 1Q23 resultsraises non-GAAP EPS guidance: | DewDiligence | investorshub | 04/27/2023 1:08:25 PM |
$MRK acquires RXDX for $10.8B | DewDiligence | investorshub | 04/17/2023 4:37:16 PM |
A Delaware judge ruled today that $MRK remains | DewDiligence | investorshub | 04/03/2023 10:07:28 PM |
Keytruda shows statsig-superior PFS as addend to chemo | DewDiligence | investorshub | 03/27/2023 9:52:42 PM |
whytestocks: $MRK News Article - KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved O | whytestocks | investorshangout | 03/10/2023 3:25:48 PM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 04:59:00 ET Some might hesitate to invest in stocks during a bull run, like the one we are experiencing. They argue that equities are likely to be overvalued. However, it's possible to find reasonably valued picks in this environment, even among top high-quality stocks. And some ...
How one employee's upbringing and career journey have motivated her to fight inequities around the world NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she's done across industries. As a young...
Symposia will highlight work to overcome HIV-related stigma and discuss the evolving state of HIV treatment and prevention Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced upcoming data presentations and programming at the 25 th International ...